• 

  How New Alzheimer’s Drugs Are Changing the Game
• 

  Biogen Slashes Aduhelm Price; EMA Rejects It in EU
• 

  Alzheimer’s Nasal Vaccine, Protollin, in Clinical Trials
• 

  Training Dogs to Diagnose Parkinson’s
• 

  High Hopes, Low Sales: Aduhelm’s Dismal Roll-Out and What’s Next for Anti-Amyloids
• 

  European Drug Regulators Don’t Want to Approve Aduhelm in E.U.
• 

  Aduhelm Blamed for Jump in Next Year’s Medicare Premium
• 

  Why Doesn’t Everyone With Amyloid Plaques Develop Alzheimer’s?
• 

  This Genetic Trait Increases Risk of Alzheimer’s and Severe COVID-19
• 

  No, Scientists Have Not Found That Certain Personality Traits Increase Alzheimer’s Risk
• 

  Seizures and Alzheimer’s: An Anti-Seizure Drug May Benefit Memory, Too
• 

  Approved “Water Pill” Bumetanide May Reduce Alzheimer’s Risk
• 

  UK Rolls Out New 5-Minute Alzheimer’s Test
• 

  A Two-Minute Test to Catch Alzheimer’s Early
• 

  Gantenerumab for Alzheimer’s Gets FDA ‘Breakthrough’ Status

Previous282930Next